Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Camacho-Carvajal, M. M.
Right arrow Articles by Steimle, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camacho-Carvajal, M. M.
Right arrow Articles by Steimle, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 16, No. 1, pp. 65-75, January 2004
© 2004 Japanese Society for Immunology

Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport

Margarita M. Camacho-Carvajal1,3, Sebastian Klingler1, Felix Schnappauf1, Sandra B. Hake2 and Viktor Steimle1,4

1 Hans-Spemann-Laboratories, Max-Planck-Institut für Immunbiologie, Freiburg D-79108, Germany 2 Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA 3 Present address: Laboratory for Physiological Chemistry and Centre for Biomedical Genetics, Utrecht 3584CG, The Netherlands 4 Present address: Département de Biologie, Université de Sherbrooke, QC J1K 2R1, Canada

Correspondence to: V. Steimle, Département de Biologie, Université de Sherbrooke, 2500 Boulevard Université, Sherbrooke, QC J1K 2R1, Canada. E-mail: viktor.steimle{at}usherbrooke.ca
Transmitting editor: L. Glimcher

Class II transactivator (CIITA), the master regulator of MHC class II (MHC-II) gene transcription, shows a complex behavior in terms of self-association, nucleo-cytoplasmic transport and MHC-II gene transactivation. Here, we analyzed the mechanisms of dominant-negative function and nucleo-cytoplasmic transport of CIITA with emphasis on the role of the C-terminal leucine-rich-repeat (LRR) region in these processes. First, we determined nucleo-cytoplasmic transport of endogenous CIITA and thus validated results obtained with epitope-tagged CIITA constructs. LRR mutations in potential protein–protein contact positions lead to either completely blocked or reduced nuclear import, but can also give rise to increased nuclear export. Surprisingly, N-terminally truncated CIITA mutants show dominant-negative inhibition of wild-type CIITA, whether they are located in the nucleus or in the cytoplasm. Integrity of the LRR is necessary for the dominant-negative function of both types of mutants. LRR mutations are dominant over the effect of an exogenously added N-terminal nuclear localization signal (NLS) leading to cytoplasmic localization. Taken together, our results show that the LRR regulate the function of one or several NLS within CIITA, and control both nuclear import and export. Self-association is not affected in these mutants; we therefore suggest that interaction of the LRR with an unknown protein partner may be necessary for import and transactivation function of CIITA.

Keywords: immune response genes, MHC class II gene regulation, transcriptional regulation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. N. Voong, A. R. Slater, S. Kratovac, and D. E. Cressman
Mitogen-activated Protein Kinase ERK1/2 Regulates the Class II Transactivator
J. Biol. Chem., April 4, 2008; 283(14): 9031 - 9039.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Skipper, H. Shen, E. Chua, C. Bonnard, P. Kolatkar, L.C.S. Tan, R. D. Jamora, K. Puvan, K. Y. Puong, Y. Zhao, et al.
Analysis of LRRK2 functional domains in nondominant Parkinson disease
Neurology, October 25, 2005; 65(8): 1319 - 1321.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xu, L. Wang, G. Buttice, P. K. Sengupta, and B. D. Smith
Major Histocompatibility Class II Transactivator (CIITA) Mediates Repression of Collagen (COL1A2) Transcription by Interferon {gamma} (IFN-{gamma})
J. Biol. Chem., October 1, 2004; 279(40): 41319 - 41332.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. F. Greer, J. A. Harton, M. W. Linhoff, C. A. Janczak, J. P.-Y. Ting, and D. E. Cressman
Serine Residues 286, 288, and 293 within the CIITA: A Mechanism for Down-Regulating CIITA Activity through Phosphorylation
J. Immunol., July 1, 2004; 173(1): 376 - 383.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.